Dental Anesthesia Market Report 2025 (Global Edition)

Global Dental Anesthesia Market Report 2025 Market Size Split by Type (Articaine, Lidocaine, Mepivacaine, Prilocaine, Bupivacaine), by Mode of Administration (Maxillary, Mandibular), by End-User (Spe...

Dental Anesthesia Market Report Description

We have various report editions of Dental Anesthesia Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Dental Anesthesia Market Insights Video

Dental Anesthesia Industry News

• Pierrel

Pierrel is a global player in the pharmaceutical market. The company provides their products in international market of USA, Canada, Italy, Russia, Poland, Serbia, France, UK, Germany, Kosovo, Austria, Sudan, Taiwan and Indonesia. Products of the company are segmented into anesthesia and prevention. Anesthesia includes articaine, mepivacaine and lidocaine-based anesthetics. Further, the company provides Goccles which helps to see the oral cavity anomalies.

December 2021

Pierrel Announced Highly innovative prototype line for sterile injectable products

The goal of the project is to "analyze, develop, design, and implement a highly innovative prototype line (pilot plant) for the development of sterile liquid injectable dental care drugs and the new Pierrel brand dental anaesthetic molecule, as well as to provide a back-up solution in the event of breakdowns or interruptions to the current production line."

November 2021

Pierrel confirmed the plan's objectives and doubles the capacity

The story from Il sole 24 ore about the plan's aims being confirmed and Pierrel's capacity being doubled. 

• Septodont Holding

Septodont Holding is a France based pharmaceutical and medical device company involved in developing, manufacturing and distributing dental consumables. The products offered by company are dental anesthesia: topical and local anesthetics, safety devices, needles, syringes and reversals and endodontics & restorative products. It also offers regeneration & surgery products.

July 2021

Septodont announced the signing of an agreement for the acquisition of four dental brands from Sanofi.

The acquired portfolio includes Ultracain, a local and infiltrative anesthetic, Rodogyl and Birodogyl, treatments of acute chronic or recurrent stomatological infections, and Dontisolon, an anti-inflammatory, decongestant and analgesic oral paste. This acquisition is helped to improve existing dental portfolio and to strengthen customer base through a broader range of products and solutions.

Top Companies Market Share in Dental Anesthesia Industry: (In no particular order of Rank)

• Septodont
• Dentsply Sirona
• ASPEN Group
• Septodont Holding
• Pierrel
• JohnsonJohnson
• Roche
• Baxter
• Abbott
• Hospira
• Hikma
• AstraZeneca
• Aspen Global Incorporated(AGI)
• Kitron
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Dental Anesthesia Market Regional Analysis

Region and country analysis section of Dental Anesthesia Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Dental Anesthesia market.

The current report Scope analyzes Dental Anesthesia Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

Dental Anesthesia Market Analysis

Dental Anesthesia Market, Type Segment Analysis

• Articaine

The Articaine segment revenue will be USD 209.87 Million by 2028 of Dental Anesthesia Market. Articaine is a safe and effective local anesthetic that can be used on patients of all ages for all standard dental operations. In several nations, it is the most extensively used local anesthetic. During dental treatments, articaine, like other local anesthetics, creates a brief and reversible state of anesthesia (lack of sensation). The FDA authorized it in April of 2000. Articaine is primarily used in dentistry for infiltration injections.

• Lidocaine

Lidocaine is the most common anesthetic used by dentists nowadays. Lidocaine, causes the skin and surrounding tissues to lose feeling. It is used to both prevent and alleviate pain associated with dental treatments. In dentistry, lidocaine is used as a 2% or 5% gel, 2% solution, 4% or 5% solution, 5% ointment, or 10% spray.

• Mepivacaine

Mepivacaine is a numbing drug that works by blocking the nerve impulses that send pain signals to the brain. It is a local anesthetic used for epidural or spinal blocks. It is also used for dental operations as an anesthetic. Mepivacaine is injected into the gum area of the mouth during a dental operation. Mepivacaine can make the patient feel numb for a lengthy time. This medicine should only be administered by or under the supervision of your doctor.

• Prilocaine

Prilocaine has a better clinical performance in terms of giving fast dental anesthetics. A prilocaine injection is used to numb the mouth before undergoing a dental operation. This medicine should only be administered by or under the supervision of the dentist. The solution dosage form of prilocaine is available. It is injected directly into the gums area.

• Bupivacaine

Bupivacaine is a local anesthetic that is used to address a specific area. Dental operations employ bupivacaine as an anesthetic. It is a molecular analog of mepivacaine with high lipid solubility and protein binding properties. When compared to other local anesthetics used in dentistry, these features contribute to bupivacaine's superior potency and anesthetic duration.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Dental Anesthesia Industry. Request a Free Sample PDF!

Dental Anesthesia Market, by Application

The Maxillary segment revenue will be USD 291.29 Million by 2028. The maxillary teeth can be anesthetized by infiltration, regional block, intraligamentary, intra-osseous and intrapulpal anesthesia. Dental anesthesia is produced by a solution deposited on the buccal side of the maxillary alveolus that can permeate through to the pulps of the teeth. This is due to the thinness of the cortical plate on the buccal side of the maxilla. Infiltration anesthesia has the advantage of being a simple procedure that is easy to master, and when successful, it anesthetizes all nerve terminals in the deposition area, regardless of the nerve source

• Mandibular

In dental clinics, mandibular is a common anesthesia route of administration. It is caused by a blockage of the auriculotemporal, inferior alveolar, buccal, mental, incisive, mylohyoid, and lingual nerves. It causes ipsilateral mandibular teeth to be anesthetized up to the midline. Mandibular anesthesia is more difficult to anesthetize than the teeth in the upper jaw (maxillary).

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Dental Anesthesia End-User Segment Analysis

• Specialized Dental Hospitals

Specialized Dental Hospitals Revenue in Dental Anesthesia is projected to reach USD 576.02 Million by 2028.

Specialized dental hospitals treated a number of patients on daily basis. This medication is administered as an injection designed to temporarily prevent the teeth’ nerve fibers from transmitting impulses, thereby numbing the area. There is several dental anesthesia are available in the market that should be administered by specialized dental doctors.

• Others

Other facilities such as clinics, hospitals also have dental departments in its place. Dental anesthesia is used by these users to treat the patients.

• Specialized Dental Hospitals
• Others

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion